Literature DB >> 816387

Purification and properties of DNA-dependent RNA polymerase from Mycobacterium tuberculosis H37RV.

R M Harshey, T Ramakrishnan.   

Abstract

RNA polymerase (nucleosidetriphosphate: RNA nucleotidyltransferase DNA-dependent), EC 2.7.7.6) was purified approximately 200 fold from Mycobacterium tuberculosis H37RV cells. The purified enzyme has a molecular weight of about 330 000-350 000 and is composed of four subunits. The subunits beta', beta and sigma have molecular weights different from those of Escherichia coli polymerase; the fourth, alpha subunit has a similar weight. The purified enzyme is a thousand-fold more sensitive to rifampicin, a potent antitubercular drug than the E. coli RNA polymerase, probably because of the difference in the beta subunits. This, with other data presented in this paper, indicate that the RNA polymerase of M. tuberculosis differs in its properties from that of E. coli.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 816387     DOI: 10.1016/0005-2787(76)90040-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1.

Authors:  G L Drusano; Arnold Louie; Alasdair MacGowan; William Hope
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

2.  Different rifampin sensitivities of Escherichia coli and Mycobacterium tuberculosis RNA polymerases are not explained by the difference in the beta-subunit rifampin regions I and II.

Authors:  N Zenkin; A Kulbachinskiy; I Bass; V Nikiforov
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  Transcriptional analysis of the principal cell division gene, ftsZ, of Mycobacterium tuberculosis.

Authors:  Sougata Roy; Parthasarathi Ajitkumar
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

4.  Production and characterization of a highly pure RNA polymerase holoenzyme from Mycobacterium tuberculosis.

Authors:  Omar Herrera-Asmat; Lucyna Lubkowska; Mikhail Kashlev; Carlos J Bustamante; Daniel G Guerra; Maria L Kireeva
Journal:  Protein Expr Purif       Date:  2017-03-18       Impact factor: 1.650

5.  Overproduction and purification of highly active recombinant Pseudomonas aeruginosa str. PAO1 RNA polymerase holoenzyme complex.

Authors:  Derrick Afful; Liming Cai; Cory Momany
Journal:  Protein Expr Purif       Date:  2019-07-04       Impact factor: 1.650

6.  Human macrophage gamma interferon decreases gene expression but not replication of Mycobacterium tuberculosis: analysis of the host-pathogen reciprocal influence on transcription in a comparison of strains H37Rv and CMT97.

Authors:  G Cappelli; P Volpe; A Sanduzzi; A Sacchi; V Colizzi; F Mariani
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

7.  Rate of ribonucleic acid chain growth in Mycobacterium tuberculosis H37Rv.

Authors:  R M Harshey; T Ramakrishnan
Journal:  J Bacteriol       Date:  1977-02       Impact factor: 3.490

8.  In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus.

Authors:  Christopher K Murphy; Steve Mullin; Marcia S Osburne; John van Duzer; Jim Siedlecki; Xiang Yu; Kathy Kerstein; Michael Cynamon; David M Rothstein
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

9.  Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin.

Authors:  Tawanda Gumbo; Arnold Louie; Mark R Deziel; Weiguo Liu; Linda M Parsons; Max Salfinger; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

10.  Thiolutin-resistant mutants of Salmonella typhimurium.

Authors:  A Joshi; M Verma; M Chakravorty
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.